The University of Pittsburgh Medical Center partnered with Ibex Medical Analytics to deploy its artificial intelligence-based tool to support pathologists in diagnosing prostate cancer.
The tool, dubbed Galen Prostate, is designed to provide diagnostic insights and clinical decision support to pathologists, according to a Dec. 14 press release from Ibex.
UPMC will digitize prostate biopsies and analyze them using the Galen platform ahead of a pathologist's review.
"Galen Prostate serves as a 'digital assistant' for our pathologists, helping automate routine processes and providing augmented insights for each biopsy," Rajiv Dhir, MD, medical director of anatomic pathology services at UPMC, said in the press release. "We look forward to expanding the deployment of this technology across our network as we adopt digital workflows that enable our pathology departments to increase efficiency, optimize workflow and ensure the highest standard of care and long-term outcomes for cancer patients."